Total Payments
$187,100
2024 Payments
$28,447
Companies
84
Transactions
2,468
Medicare Patients
10,707
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$68,640 (36.7%)
Consulting$61,244 (32.7%)
Food & Beverage$41,496 (22.2%)
Travel$15,374 (8.2%)
Education$345.91 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,390 | 50 | 35.5% |
| Consulting Fee | $61,244 | 34 | 32.7% |
| Food and Beverage | $41,496 | 2,291 | 22.2% |
| Travel and Lodging | $15,374 | 80 | 8.2% |
| Honoraria | $2,250 | 1 | 1.2% |
| Education | $345.91 | 12 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $87,165 | 329 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $30,009 | 193 | $0 (2024) |
| PFIZER INC. | $15,683 | 123 | $0 (2024) |
| ABBVIE INC. | $12,039 | 214 | $0 (2024) |
| Allergan, Inc. | $4,984 | 65 | $0 (2020) |
| Novo Nordisk Inc | $4,155 | 253 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $3,754 | 5 | $0 (2017) |
| AstraZeneca AB | $3,262 | 2 | $0 (2020) |
| GlaxoSmithKline, LLC. | $2,597 | 118 | $0 (2024) |
| Daiichi Sankyo Inc. | $1,812 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,447 | 280 | AstraZeneca Pharmaceuticals LP ($17,052) |
| 2023 | $34,656 | 352 | AstraZeneca Pharmaceuticals LP ($14,768) |
| 2022 | $11,298 | 302 | AstraZeneca Pharmaceuticals LP ($6,491) |
| 2021 | $8,881 | 305 | AstraZeneca Pharmaceuticals LP ($2,685) |
| 2020 | $14,813 | 265 | AstraZeneca Pharmaceuticals LP ($5,863) |
| 2019 | $27,739 | 343 | AstraZeneca Pharmaceuticals LP ($17,240) |
| 2018 | $24,446 | 282 | Janssen Pharmaceuticals, Inc ($12,275) |
| 2017 | $36,819 | 339 | AstraZeneca Pharmaceuticals LP ($17,608) |
All Payment Transactions
2,468 individual payment records from CMS Open Payments — Page 1 of 99
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: PAIN | ||||||
| 12/18/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.81 | General |
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: CNS | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.60 | General |
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.58 | General |
| Category: Opioid Analgesic | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Endocrinology | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Biological | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Insomnia | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,471 | 4,392 | $540,862 | $307,855 |
| 2022 | 27 | 2,421 | 4,365 | $497,676 | $282,905 |
| 2021 | 35 | 3,142 | 5,106 | $559,805 | $336,574 |
| 2020 | 32 | 2,673 | 5,428 | $577,736 | $313,279 |
Total Patients
10,707
Total Services
19,291
Medicare Billing
$1.2M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 241 | 1,385 | $166,083 | $81,088 | 48.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 295 | 710 | $117,150 | $67,120 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 266 | 266 | $53,200 | $36,163 | 68.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 43 | 56 | $19,600 | $13,042 | 66.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 160 | $17,600 | $10,840 | 61.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 173 | 173 | $21,625 | $10,678 | 49.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 133 | 138 | $13,800 | $9,906 | 71.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 53 | 59 | $14,750 | $8,943 | 60.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 65 | 94 | $12,690 | $8,354 | 65.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $6,900 | $6,482 | 93.9% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 91 | 91 | $11,830 | $6,415 | 54.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 45 | $9,900 | $6,314 | 63.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 112 | 233 | $11,650 | $6,258 | 53.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 27 | 62 | $12,400 | $5,745 | 46.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 245 | 245 | $6,125 | $4,797 | 78.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 144 | 150 | $5,250 | $4,423 | 84.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 81 | $5,265 | $3,309 | 62.8% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 21 | 21 | $4,200 | $2,684 | 63.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,750 | $2,611 | 69.6% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 31 | 34 | $4,250 | $2,135 | 50.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,000 | $2,063 | 68.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,299 | $2,051 | 47.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 18 | 23 | $2,070 | $1,180 | 57.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,465 | $1,135 | 32.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 98 | 121 | $2,420 | $1,016 | 42.0% |
About Dr. Peter Honig, DO
Dr. Peter Honig, DO is a Adult Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194777466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Honig, DO has received a total of $187,100 in payments from pharmaceutical and medical device companies, with $28,447 received in 2024. These payments were reported across 2,468 transactions from 84 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($66,390).
As a Medicare-enrolled provider, Honig has provided services to 10,707 Medicare beneficiaries, totaling 19,291 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Medicine
- Location Philadelphia, PA
- Active Since 05/16/2006
- Last Updated 02/23/2012
- Taxonomy Code 207QA0505X
- Entity Type Individual
- NPI Number 1194777466
Products in Payments
- INVOKANA (Drug) $28,300
- AIRSUPRA (Drug) $22,765
- FASENRA (Drug) $20,410
- BEVESPI AEROSPHERE (Drug) $12,269
- SYMBICORT (Drug) $11,492
- BREZTRI (Drug) $7,885
- VRAYLAR (Drug) $6,851
- Creon (Drug) $3,899
- CONTRAVE (Drug) $3,754
- UBRELVY (Drug) $2,709
- FASENRA (Biological) $2,494
- BOTOX - MIGRAINE (Drug) $1,800
- Ozempic (Drug) $1,705
- XARELTO (Drug) $1,703
- Kerendia (Drug) $1,161
- TRELEGY ELLIPTA (Drug) $1,129
- XIFAXAN (Drug) $983.81
- JARDIANCE (Drug) $875.30
- FARXIGA (Drug) $860.10
- REXULTI (Drug) $837.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Medicine Doctors in Philadelphia
Dr. Mark Watkins, Do, DO
Adult Medicine — Payments: $75,355
Adult Medicine $75,355
Dr. Harvey Spector, D.o, D.O
Adult Medicine — Payments: $21,425
Adult Medicine $21,425
Dr. James Tweedy, D.o, D.O
Adult Medicine — Payments: $1,969
Adult Medicine $1,969
Dr. Amy Orloff-Fine, Do, DO
Adult Medicine — Payments: $1,901
Adult Medicine $1,901
Dr. Agnes Simmons, M. D, M. D
Adult Medicine — Payments: $1,723
Adult Medicine $1,723
Paul Le
Adult Medicine — Payments: $1,163
Adult Medicine $1,163